Wave Life Sciences Ltd
Research Wave Life Sciences Ltd (WVE) on Bullrun: market cap USD 1.01B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWVE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.01B
- Financial periodQ2 2026
- RevenueUSD 2.27M
- Net income-USD 69.36M
- Free cash flow-USD 54.47M
Valuation Snapshot
latest market cap is USD 1.01B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 42.73M | -USD 204.38M | -USD 188.21M | n/a | -1.21 | USD 602.07M | USD 17.77M | USD 518.36M |
| FY2024 | USD 108.30M | -USD 97.01M | -USD 151.96M | n/a | -0.7 | USD 302.08M | USD 25.40M | USD 209.52M |
| FY2023 | USD 113.31M | -USD 57.51M | -USD 20.55M | n/a | -0.54 | USD 200.35M | USD 32.12M | USD 39.63M |
| FY2022 | USD 3.65M | -USD 161.82M | -USD 129.14M | n/a | -2.05 | USD 88.50M | USD 39.52M | -USD 45.09M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.01B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.19B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.89B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 601.65M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 608.37M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 187.90M | n/a | n/a | n/a |
About Wave Life Sciences Ltd
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Wave Life Sciences Ltd's market cap?
Wave Life Sciences Ltd's market capitalization is USD 1.01B.
What does Wave Life Sciences Ltd do?
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders.